Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

N-acetyltransferase 2 genotype in colorectal cancer and selective gene retention in cancers with chromosome 8p deletions.

Gut - 1 Aug 1997

Hubbard A L, Harrison D J, Moyes C, Wyllie A H, Cunningham C, Mannion E, Smith C A

Abstract excerpt

BACKGROUND: Genetic polymorphisms in N-acetyltransferase (NAT2) can change the normally fast acetylation of substrates to slow acetylation, and have been associated with the development of some cancers. The NAT2 locus may also suffer dysregulation during cancer progression, as the gene resides on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Alleles
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chromosome Deletion

Share to Genetic Markers

Share to Genotype

Share to Heterozygote

Share to Polymerase Chain Reaction

Source

Open in PubMed Open full text

Identifiers

PMID: 9301503
DOI: 10.1136/gut.41.2.229
PMCID: PMC1891458

Genes

NAT2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-9301503-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

N-acetyltransferase 2 genotype in colorectal cancer and selective gene retention in cancers with chromosome 8p deletions.PMID 9301503Read ↗

N-acetyltransferase polymorphisms and colorectal cancer: a HuGE review.Semantic proximity Read ↗

Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer.Semantic proximity Read ↗

Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy.Semantic proximity Read ↗

N-acetyltransferase 2 (NAT2) gene polymorphisms in colon and lung cancer patients.Semantic proximity Read ↗

Characterization of N-acetyltransferase 1 and 2 polymorphisms and haplotype analysis for inflammatory bowel disease and sporadic colorectal carcinoma.Semantic proximity Read ↗

Somatic mutations, acetylator status, and prognosis in colorectal cancer.Semantic proximity Read ↗

Genotyping of the polymorphic N-acetyltransferase (NAT2) and loss of heterozygosity in bladder cancer patients.Semantic proximity Read ↗

N-Acetyltransferase (NAT) 2 acetylator status and age of tumour onset in patients with sporadic and familial, microsatellite stable (MSS) colorectal cancer.Semantic proximity Read ↗

N-acetyltransferase 2 single-nucleotide polymorphisms and risk of gastric carcinoma.Semantic proximity Read ↗

Absence of association between N-acetyltransferase 2 acetylator status and colorectal cancer susceptibility: based on evidence from 40 studies.Semantic proximity Read ↗

A meta-analysis of the relationship between NAT2 polymorphism and colorectal cancer susceptibility.Semantic proximity Read ↗

NAT2 gene polymorphism and sporadic colorectal cancer. Prevalence, tumor stage and prognosis. A preliminary study in 70 patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.